logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    
Alibaba ($BABA) is the largest online and mobile commerce company in the world in terms of gross merchandise volume in 2013, according to the IDC GMV (Gross Merchandise Value) Report. It is based in Hong Kong, China. Price range raised to $66-68, from $60-66. Six other companies are scheduled for…
Read more...
ProQR Therapeutics B.V. ($PRQR) is an innovative biopharmaceutical company engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, including a disease modifying therapy for the treatment of cystic fibrosis. It is based in Leiden, Netherlands. Six other companies are scheduled for the week…
Read more...
Foamix Ltd. ($FOMX) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing its proprietary minocycline foam for the treatment of acne, impetigo and other skin conditions. It is based in Rehovot, Israel. Six other companies are scheduled for the week of Sept. 15, 2014 including Alibaba. The full…
Read more...
Viking Therapeutics ($VKTX) is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. It is headquartered in San Diego, CA. Six other companies are scheduled for the week of Sept. 15, 2014, including Alibaba. The full IPO calendar is available…
Read more...
Civitas Solutions ($CIVI) is the leading national provider of home- and community-based health and human services to must-serve individuals with intellectual, developmental, physical or behavioral disabilities and other special needs. It is based in Boston. Six other companies are scheduled for the week of Sept. 15, 2014, including Alibaba. The…
Read more...
Tokai Pharmaceuticals ($TKAI) is a clinical-stage biopharmaceutical company focused on developing novel proprietary therapies for the treatment of prostate cancer and other hormonally-driven diseases. It is based in Cambridge, MA. Six other companies are scheduled for the week of Sept. 15, 2014, including Alibaba. The full IPO calendar is available…
Read more...
rEVO Biologics ($RBIO) is a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. It is based in Framingham, MA. Six other companies are scheduled for the week of Sept. 15, 2014, including Alibaba. The full…
Read more...
On Sept. 15, Alibaba announced they would ratchet up their IPO price to just under $70 a share, a considerable uptick from the previously widely reported $66 a share number. The move itself indicates how wildly speculative the tech IPO market has become, and how deeply frightened founder Jack Ma…
Read more...
Full IPO calendar & reports HERE, including the $20 billion Alibaba (BABA) IPO.  In order of largest IPO first.  (1) Based in Hong Kong, China, Alibaba (BABA) filed for a $20.2 billion IPOs Friday, September 5, 2014, with a market cap of $155 billion, at a price range mid-point of…
Read more...
ReWalk Robotics (RWLK), based in Yokneam, Israel,is an innovative medical device company that is designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. Two companies are scheduled for the week of September 8, 2014.  The…
Read more...
Affimed Therapeutics B.V. (AFMD), based in Heidelberg, Germany is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Two companies are scheduled for the week of September 8, 2014.  The complete IPO calendar is available at IPOpremium.  Alibaba is scheduled for next week. Manager, Co-Managers: Jefferies &…
Read more...
Full IPO calendar & reports HERE, including the $20 billion Alibaba ($BABA) IPO.  In order of largest IPO first.  (1) Based in Heidelberg, Germany, Affimed Therapeutics B.V. ($AFMD) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $267 million at a price range midpoint of $12…
Read more...
Page 1 of 34

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.